Metis Global Partners’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Metis Global Partners's PBYI Position: Q3 2026 in Review
Metis Global Partners held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 25,264 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #627.
Metis Global Partners first reported a position in PBYI in Q1 2024 and has held it in 11 quarters since. The position peaked at $296K in Q3 2025. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Metis Global Partners held 25,264 shares of Puma Biotechnology worth $251K as of Q3 2026.
- Metis Global Partners left its Puma Biotechnology share count unchanged in Q3 2026.
- Puma Biotechnology made up 0.01% of Metis Global Partners's portfolio in Q3 2026, its #627 holding.
- Metis Global Partners first reported a position in Puma Biotechnology in Q1 2024 and has held it in 11 quarters since.
- Metis Global Partners's Puma Biotechnology position peaked at $296K in Q3 2025.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Metis Global Partners's 13F filing for Q3 2026, filed 13 Nov 2026.